 Peter Dempsey
Concepts (649)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| ADAM Proteins | 25 | 2015 | 58 | 3.130 |
Why?
| | Amyloid Precursor Protein Secretases | 13 | 2021 | 71 | 2.260 |
Why?
| | Membrane Proteins | 19 | 2022 | 1019 | 1.770 |
Why?
| | Intestines | 7 | 2023 | 322 | 1.630 |
Why?
| | ADAM10 Protein | 15 | 2022 | 27 | 1.460 |
Why?
| | Stem Cell Niche | 3 | 2021 | 42 | 1.410 |
Why?
| | Cell Plasticity | 2 | 2021 | 23 | 1.400 |
Why?
| | Transforming Growth Factor alpha | 25 | 2013 | 53 | 1.350 |
Why?
| | ErbB Receptors | 27 | 2018 | 555 | 1.340 |
Why?
| | Receptors, Notch | 3 | 2020 | 85 | 1.230 |
Why?
| | Metalloendopeptidases | 13 | 2017 | 55 | 1.220 |
Why?
| | Breast Neoplasms | 27 | 2014 | 1865 | 1.190 |
Why?
| | Intercellular Signaling Peptides and Proteins | 14 | 2013 | 349 | 1.130 |
Why?
| | Ultrasonography, Mammary | 8 | 2010 | 11 | 1.000 |
Why?
| | Protein Precursors | 7 | 2010 | 119 | 0.970 |
Why?
| | Integrases | 2 | 2018 | 116 | 0.940 |
Why?
| | Mammography | 17 | 2010 | 106 | 0.890 |
Why?
| | Organoids | 8 | 2023 | 74 | 0.890 |
Why?
| | Breast | 11 | 2010 | 139 | 0.820 |
Why?
| | Paneth Cells | 3 | 2018 | 17 | 0.780 |
Why?
| | Intestinal Mucosa | 8 | 2023 | 528 | 0.780 |
Why?
| | Biopsy, Needle | 8 | 2010 | 183 | 0.750 |
Why?
| | ADAM17 Protein | 17 | 2022 | 31 | 0.690 |
Why?
| | Intestinal Neoplasms | 2 | 2018 | 24 | 0.690 |
Why?
| | alpha-Defensins | 1 | 2018 | 11 | 0.650 |
Why?
| | Signal Transduction | 25 | 2018 | 4527 | 0.640 |
Why?
| | Parenteral Nutrition, Total | 2 | 2015 | 34 | 0.630 |
Why?
| | Epidermal Growth Factor | 13 | 2015 | 162 | 0.570 |
Why?
| | Proteolysis | 1 | 2017 | 144 | 0.560 |
Why?
| | Carcinogenesis | 2 | 2018 | 178 | 0.550 |
Why?
| | Breast Diseases | 4 | 2010 | 20 | 0.510 |
Why?
| | Neuroendocrine Tumors | 1 | 2016 | 83 | 0.500 |
Why?
| | Animals | 66 | 2023 | 31884 | 0.490 |
Why?
| | Mice | 43 | 2023 | 14934 | 0.480 |
Why?
| | Regeneration | 3 | 2021 | 161 | 0.480 |
Why?
| | Cell Membrane | 9 | 2017 | 681 | 0.470 |
Why?
| | Epithelial Cells | 11 | 2023 | 956 | 0.470 |
Why?
| | Carcinoma, Lobular | 4 | 2014 | 44 | 0.450 |
Why?
| | Gastrointestinal Tract | 1 | 2015 | 169 | 0.440 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2015 | 1138 | 0.440 |
Why?
| | Metalloproteases | 6 | 2017 | 37 | 0.440 |
Why?
| | Neoplasms | 6 | 2017 | 2106 | 0.430 |
Why?
| | Radiographic Image Enhancement | 3 | 2008 | 57 | 0.420 |
Why?
| | Stem Cells | 3 | 2020 | 547 | 0.400 |
Why?
| | Cell Line | 19 | 2014 | 2645 | 0.380 |
Why?
| | Cell Proliferation | 10 | 2021 | 2192 | 0.370 |
Why?
| | Radiology | 1 | 2014 | 193 | 0.370 |
Why?
| | Mass Screening | 5 | 2009 | 1011 | 0.360 |
Why?
| | Gene Targeting | 1 | 2010 | 75 | 0.360 |
Why?
| | Mice, Knockout | 12 | 2015 | 2586 | 0.350 |
Why?
| | Unnecessary Procedures | 1 | 2010 | 43 | 0.340 |
Why?
| | Tamoxifen | 1 | 2010 | 192 | 0.340 |
Why?
| | Inflammation | 5 | 2019 | 2485 | 0.320 |
Why?
| | Terminology as Topic | 2 | 2007 | 186 | 0.310 |
Why?
| | Radiographic Magnification | 1 | 2008 | 1 | 0.310 |
Why?
| | Stomach | 3 | 2009 | 101 | 0.310 |
Why?
| | Thinness | 1 | 2008 | 87 | 0.300 |
Why?
| | Apoptosis | 10 | 2021 | 2368 | 0.290 |
Why?
| | Growth Substances | 6 | 1999 | 137 | 0.280 |
Why?
| | Humans | 80 | 2021 | 115222 | 0.280 |
Why?
| | Homeostasis | 2 | 2021 | 578 | 0.270 |
Why?
| | Peptide Fragments | 2 | 2010 | 668 | 0.270 |
Why?
| | Insulin-Secreting Cells | 1 | 2010 | 318 | 0.270 |
Why?
| | Hyperplasia | 3 | 2018 | 165 | 0.270 |
Why?
| | Glycoproteins | 8 | 2008 | 305 | 0.270 |
Why?
| | Phenylmercuric Acetate | 2 | 2008 | 2 | 0.260 |
Why?
| | Muscle, Smooth, Vascular | 6 | 2008 | 417 | 0.260 |
Why?
| | Transcriptional Activation | 6 | 2013 | 337 | 0.260 |
Why?
| | Amino Acid Sequence | 12 | 2017 | 1990 | 0.250 |
Why?
| | Drug Delivery Systems | 1 | 2008 | 296 | 0.250 |
Why?
| | Cell Lineage | 2 | 2018 | 310 | 0.240 |
Why?
| | Protein Processing, Post-Translational | 6 | 2007 | 399 | 0.230 |
Why?
| | Allyl Compounds | 2 | 2022 | 15 | 0.230 |
Why?
| | Protein Structure, Tertiary | 8 | 2010 | 798 | 0.220 |
Why?
| | beta Catenin | 2 | 2023 | 220 | 0.220 |
Why?
| | Energy Metabolism | 1 | 2008 | 730 | 0.220 |
Why?
| | Sulfides | 2 | 2022 | 94 | 0.220 |
Why?
| | Cell Differentiation | 7 | 2014 | 1700 | 0.220 |
Why?
| | Mice, Inbred C57BL | 12 | 2021 | 4718 | 0.210 |
Why?
| | Molecular Sequence Data | 11 | 2011 | 2797 | 0.210 |
Why?
| | Mice, Transgenic | 11 | 2020 | 1956 | 0.210 |
Why?
| | Betacellulin | 5 | 2010 | 6 | 0.200 |
Why?
| | Enzyme Inhibitors | 6 | 2008 | 753 | 0.200 |
Why?
| | Mechanotransduction, Cellular | 1 | 2023 | 97 | 0.200 |
Why?
| | Calcium | 5 | 2010 | 1104 | 0.200 |
Why?
| | Dogs | 7 | 2011 | 340 | 0.190 |
Why?
| | Female | 40 | 2021 | 59720 | 0.190 |
Why?
| | Ultrasonography | 8 | 2009 | 641 | 0.190 |
Why?
| | Microscopy | 1 | 2022 | 125 | 0.180 |
Why?
| | Angiotensin II | 3 | 2008 | 91 | 0.180 |
Why?
| | Gamma Rays | 1 | 2021 | 47 | 0.180 |
Why?
| | Receptor, ErbB-4 | 3 | 2017 | 18 | 0.180 |
Why?
| | Taste Buds | 1 | 2023 | 209 | 0.180 |
Why?
| | Immunohistochemistry | 6 | 2010 | 1635 | 0.180 |
Why?
| | Doxorubicin | 3 | 2018 | 285 | 0.180 |
Why?
| | Cell Movement | 4 | 2021 | 866 | 0.170 |
Why?
| | Colitis | 2 | 2019 | 226 | 0.170 |
Why?
| | Photolysis | 1 | 2020 | 79 | 0.170 |
Why?
| | Antiporters | 1 | 2019 | 18 | 0.170 |
Why?
| | Radiation Injuries | 1 | 2021 | 127 | 0.170 |
Why?
| | Cell Survival | 2 | 2014 | 1022 | 0.170 |
Why?
| | Gastric Mucosa | 7 | 2009 | 46 | 0.170 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2021 | 167 | 0.170 |
Why?
| | History, 21st Century | 2 | 2014 | 161 | 0.170 |
Why?
| | Colon | 3 | 2017 | 233 | 0.170 |
Why?
| | History, 20th Century | 2 | 2014 | 269 | 0.160 |
Why?
| | Gene Deletion | 2 | 2018 | 356 | 0.160 |
Why?
| | Cell Dedifferentiation | 1 | 2018 | 28 | 0.160 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2018 | 18 | 0.160 |
Why?
| | Multipotent Stem Cells | 1 | 2018 | 18 | 0.160 |
Why?
| | Acidosis | 1 | 2019 | 87 | 0.160 |
Why?
| | Fibrosis | 1 | 2021 | 455 | 0.160 |
Why?
| | T-Lymphocytes | 4 | 2013 | 1748 | 0.160 |
Why?
| | Mitosis | 2 | 2018 | 164 | 0.160 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2021 | 208 | 0.160 |
Why?
| | Clone Cells | 1 | 2018 | 248 | 0.150 |
Why?
| | Sulfhydryl Compounds | 1 | 2020 | 177 | 0.150 |
Why?
| | Atrophy | 2 | 2015 | 152 | 0.150 |
Why?
| | Ligands | 8 | 2022 | 565 | 0.150 |
Why?
| | Leptin | 2 | 2010 | 212 | 0.150 |
Why?
| | Cells, Cultured | 15 | 2019 | 3897 | 0.150 |
Why?
| | Adhesins, Bacterial | 1 | 2017 | 36 | 0.150 |
Why?
| | Cysteine Endopeptidases | 1 | 2017 | 60 | 0.150 |
Why?
| | STAT3 Transcription Factor | 2 | 2018 | 174 | 0.150 |
Why?
| | Antineoplastic Agents | 2 | 2008 | 1882 | 0.150 |
Why?
| | Goblet Cells | 2 | 2014 | 16 | 0.140 |
Why?
| | Hydrogels | 2 | 2022 | 575 | 0.140 |
Why?
| | Cell Polarity | 5 | 2003 | 131 | 0.140 |
Why?
| | Keratinocytes | 6 | 2010 | 216 | 0.140 |
Why?
| | Neutrophils | 2 | 2019 | 1163 | 0.140 |
Why?
| | Adenoma | 1 | 2018 | 187 | 0.140 |
Why?
| | Endothelial Cells | 1 | 2022 | 686 | 0.140 |
Why?
| | Cytokines | 2 | 2015 | 1843 | 0.140 |
Why?
| | Gene Expression Regulation | 4 | 2014 | 2330 | 0.130 |
Why?
| | Receptors, Antigen, T-Cell | 2 | 2013 | 629 | 0.130 |
Why?
| | Receptor, ErbB-2 | 3 | 2007 | 300 | 0.130 |
Why?
| | Base Sequence | 6 | 2011 | 2120 | 0.130 |
Why?
| | Magnetic Resonance Imaging | 2 | 2009 | 3128 | 0.130 |
Why?
| | Alleles | 1 | 2018 | 792 | 0.130 |
Why?
| | Myocytes, Smooth Muscle | 3 | 2008 | 236 | 0.130 |
Why?
| | Sensitivity and Specificity | 5 | 2008 | 1717 | 0.130 |
Why?
| | Antibodies, Monoclonal | 7 | 2000 | 1268 | 0.130 |
Why?
| | X-Ray Intensifying Screens | 2 | 2006 | 2 | 0.130 |
Why?
| | Intestine, Small | 2 | 2018 | 125 | 0.130 |
Why?
| | Time Factors | 6 | 2014 | 6157 | 0.130 |
Why?
| | Gene Knockout Techniques | 1 | 2015 | 99 | 0.120 |
Why?
| | Receptor, Notch2 | 2 | 2011 | 14 | 0.120 |
Why?
| | Receptor, Notch1 | 2 | 2013 | 59 | 0.120 |
Why?
| | Phenotype | 4 | 2014 | 2814 | 0.120 |
Why?
| | Amyloid beta-Protein Precursor | 2 | 2012 | 54 | 0.120 |
Why?
| | Enteroendocrine Cells | 1 | 2014 | 5 | 0.120 |
Why?
| | B-Lymphocytes | 3 | 2010 | 772 | 0.120 |
Why?
| | Lateral Ventricles | 1 | 2014 | 24 | 0.120 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2010 | 928 | 0.120 |
Why?
| | Kidney | 4 | 2000 | 1188 | 0.120 |
Why?
| | Neoplasm Staging | 5 | 2018 | 1171 | 0.120 |
Why?
| | Solubility | 3 | 2020 | 224 | 0.120 |
Why?
| | Interleukin-6 | 1 | 2018 | 676 | 0.110 |
Why?
| | Pancreatic Neoplasms | 1 | 2021 | 722 | 0.110 |
Why?
| | ROC Curve | 4 | 2008 | 447 | 0.110 |
Why?
| | Anesthesia, Local | 1 | 1993 | 15 | 0.110 |
Why?
| | Cell Nucleus | 3 | 2018 | 556 | 0.110 |
Why?
| | Hydrolysis | 4 | 2010 | 174 | 0.110 |
Why?
| | Immunoreceptor Tyrosine-Based Activation Motif | 1 | 2013 | 1 | 0.110 |
Why?
| | Probiotics | 1 | 2013 | 46 | 0.110 |
Why?
| | Cadherins | 1 | 2014 | 175 | 0.110 |
Why?
| | Gastritis, Hypertrophic | 1 | 1992 | 3 | 0.110 |
Why?
| | Tumor Cells, Cultured | 6 | 2021 | 851 | 0.110 |
Why?
| | Neural Stem Cells | 1 | 2014 | 115 | 0.110 |
Why?
| | Diagnosis, Differential | 3 | 2007 | 1356 | 0.110 |
Why?
| | Protease Inhibitors | 3 | 2012 | 100 | 0.110 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2017 | 288 | 0.110 |
Why?
| | CD3 Complex | 1 | 2013 | 92 | 0.110 |
Why?
| | Skin | 3 | 2010 | 659 | 0.100 |
Why?
| | Toll-Like Receptor 4 | 1 | 2015 | 286 | 0.100 |
Why?
| | Reproducibility of Results | 5 | 2020 | 2806 | 0.100 |
Why?
| | Protein Kinase C | 4 | 2003 | 275 | 0.100 |
Why?
| | Macrophages | 2 | 2017 | 1267 | 0.100 |
Why?
| | Ultrasonography, Interventional | 3 | 2010 | 123 | 0.100 |
Why?
| | Blotting, Western | 4 | 2008 | 1150 | 0.100 |
Why?
| | EGF Family of Proteins | 6 | 2008 | 15 | 0.100 |
Why?
| | Amphiregulin | 6 | 2008 | 21 | 0.100 |
Why?
| | Cell Division | 7 | 2004 | 759 | 0.100 |
Why?
| | Genes, ras | 3 | 1998 | 91 | 0.100 |
Why?
| | Extracellular Matrix | 3 | 2022 | 436 | 0.100 |
Why?
| | Protein Kinase C-delta | 3 | 2008 | 70 | 0.090 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2020 | 386 | 0.090 |
Why?
| | Biopsy, Fine-Needle | 2 | 2009 | 64 | 0.090 |
Why?
| | Mice, Mutant Strains | 2 | 2008 | 272 | 0.090 |
Why?
| | Galactosides | 1 | 2010 | 3 | 0.090 |
Why?
| | Presenilin-2 | 1 | 2010 | 3 | 0.090 |
Why?
| | Estrogen Antagonists | 1 | 2010 | 39 | 0.090 |
Why?
| | Recovery of Function | 1 | 2014 | 577 | 0.090 |
Why?
| | Lipoylation | 1 | 2010 | 16 | 0.090 |
Why?
| | Presenilin-1 | 1 | 2010 | 27 | 0.090 |
Why?
| | Crosses, Genetic | 1 | 2010 | 140 | 0.090 |
Why?
| | Peptides | 1 | 1995 | 849 | 0.090 |
Why?
| | Male | 14 | 2017 | 55814 | 0.090 |
Why?
| | Adult | 16 | 2010 | 30711 | 0.090 |
Why?
| | Hydrogen Peroxide | 3 | 2006 | 287 | 0.090 |
Why?
| | Receptors, IgE | 1 | 2010 | 40 | 0.090 |
Why?
| | TRPV Cation Channels | 1 | 2010 | 28 | 0.090 |
Why?
| | Transfection | 6 | 2006 | 872 | 0.090 |
Why?
| | Hair | 1 | 2010 | 65 | 0.090 |
Why?
| | Genes, Reporter | 1 | 2010 | 257 | 0.090 |
Why?
| | Antigens, CD | 3 | 2007 | 441 | 0.080 |
Why?
| | Gene Expression Regulation, Neoplastic | 4 | 2018 | 1145 | 0.080 |
Why?
| | Radiography | 3 | 2014 | 827 | 0.080 |
Why?
| | Kinetics | 4 | 2005 | 1558 | 0.080 |
Why?
| | Middle Aged | 14 | 2007 | 26873 | 0.080 |
Why?
| | Immunoglobulin G | 2 | 2010 | 775 | 0.080 |
Why?
| | Helicobacter Infections | 1 | 2009 | 25 | 0.080 |
Why?
| | Calcinosis | 2 | 2006 | 242 | 0.080 |
Why?
| | Cell Line, Tumor | 5 | 2018 | 2715 | 0.080 |
Why?
| | Uncoupling Protein 1 | 1 | 2008 | 16 | 0.080 |
Why?
| | Arcuate Nucleus of Hypothalamus | 1 | 2008 | 13 | 0.080 |
Why?
| | Fats | 1 | 2008 | 12 | 0.080 |
Why?
| | Fluorescent Dyes | 1 | 2010 | 300 | 0.080 |
Why?
| | Disintegrins | 2 | 2007 | 5 | 0.080 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2006 | 1354 | 0.080 |
Why?
| | HEK293 Cells | 3 | 2017 | 590 | 0.080 |
Why?
| | Swine | 1 | 2010 | 705 | 0.080 |
Why?
| | Ion Channels | 1 | 2008 | 124 | 0.080 |
Why?
| | Bacterial Proteins | 1 | 2013 | 736 | 0.080 |
Why?
| | Enzyme Precursors | 1 | 2007 | 15 | 0.070 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2006 | 192 | 0.070 |
Why?
| | Isoenzymes | 2 | 2000 | 286 | 0.070 |
Why?
| | Lymphocyte Activation | 2 | 2013 | 1042 | 0.070 |
Why?
| | Intercellular Junctions | 2 | 2000 | 33 | 0.070 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2007 | 33 | 0.070 |
Why?
| | Hypothalamus | 1 | 2008 | 147 | 0.070 |
Why?
| | Efficiency | 1 | 2008 | 84 | 0.070 |
Why?
| | Disease Models, Animal | 5 | 2019 | 3547 | 0.070 |
Why?
| | Observer Variation | 1 | 2008 | 298 | 0.070 |
Why?
| | Colorectal Neoplasms | 2 | 2018 | 617 | 0.070 |
Why?
| | Ultrasonography, Doppler | 1 | 2007 | 106 | 0.070 |
Why?
| | Early Detection of Cancer | 1 | 2010 | 339 | 0.070 |
Why?
| | Adipocytes | 1 | 2008 | 189 | 0.070 |
Why?
| | Cell Transformation, Neoplastic | 3 | 2000 | 311 | 0.070 |
Why?
| | United States | 3 | 2014 | 12256 | 0.070 |
Why?
| | Heparin-binding EGF-like Growth Factor | 3 | 2013 | 11 | 0.070 |
Why?
| | Mitochondrial Proteins | 1 | 2008 | 220 | 0.070 |
Why?
| | Phosphorylation | 6 | 2013 | 1574 | 0.070 |
Why?
| | Receptor, ErbB-3 | 1 | 2006 | 41 | 0.070 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2008 | 243 | 0.070 |
Why?
| | Cell Line, Transformed | 2 | 2004 | 133 | 0.070 |
Why?
| | Eating | 1 | 2008 | 347 | 0.070 |
Why?
| | Tyrosine | 3 | 2008 | 216 | 0.060 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2004 | 796 | 0.060 |
Why?
| | Receptors, Progesterone | 1 | 2007 | 319 | 0.060 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2006 | 102 | 0.060 |
Why?
| | Receptor, Angiotensin, Type 2 | 1 | 2005 | 8 | 0.060 |
Why?
| | Fibromatosis, Aggressive | 1 | 2005 | 18 | 0.060 |
Why?
| | RNA, Messenger | 7 | 2018 | 2563 | 0.060 |
Why?
| | Nucleoside-Phosphate Kinase | 1 | 2005 | 1 | 0.060 |
Why?
| | Neoplasm, Residual | 1 | 2006 | 105 | 0.060 |
Why?
| | Colonic Neoplasms | 2 | 1999 | 222 | 0.060 |
Why?
| | Receptors, Estrogen | 1 | 2007 | 372 | 0.060 |
Why?
| | Endothelin-1 | 1 | 2006 | 167 | 0.060 |
Why?
| | Biological Transport | 3 | 2008 | 372 | 0.060 |
Why?
| | Organ Culture Techniques | 3 | 2014 | 141 | 0.060 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2006 | 332 | 0.060 |
Why?
| | Ion Transport | 1 | 2004 | 55 | 0.060 |
Why?
| | GTP-Binding Proteins | 1 | 2005 | 141 | 0.060 |
Why?
| | Neurons | 1 | 2012 | 1285 | 0.060 |
Why?
| | Physical Examination | 1 | 2006 | 221 | 0.060 |
Why?
| | Gastric Acid | 2 | 1995 | 13 | 0.060 |
Why?
| | Chemokines, CXC | 1 | 2004 | 58 | 0.060 |
Why?
| | Mutation | 5 | 2010 | 3350 | 0.060 |
Why?
| | Up-Regulation | 2 | 2019 | 812 | 0.060 |
Why?
| | Heparin | 1 | 2005 | 222 | 0.060 |
Why?
| | Rats | 8 | 2008 | 4980 | 0.060 |
Why?
| | Motor Activity | 1 | 2008 | 643 | 0.060 |
Why?
| | Leiomyosarcoma | 1 | 2003 | 26 | 0.060 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2003 | 35 | 0.060 |
Why?
| | DNA Primers | 1 | 2004 | 515 | 0.060 |
Why?
| | Aged | 8 | 2007 | 19136 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinases | 2 | 2004 | 278 | 0.050 |
Why?
| | Receptor Protein-Tyrosine Kinases | 2 | 2003 | 226 | 0.050 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2007 | 699 | 0.050 |
Why?
| | Mammary Glands, Animal | 2 | 1995 | 116 | 0.050 |
Why?
| | Receptors, Immunologic | 1 | 2004 | 201 | 0.050 |
Why?
| | Uterine Neoplasms | 1 | 2003 | 73 | 0.050 |
Why?
| | Amino Acid Motifs | 1 | 2003 | 198 | 0.050 |
Why?
| | Tongue | 1 | 2023 | 67 | 0.050 |
Why?
| | Molecular Weight | 2 | 1997 | 331 | 0.050 |
Why?
| | Leucine | 1 | 2003 | 107 | 0.050 |
Why?
| | Receptors, Cell Surface | 2 | 2022 | 356 | 0.050 |
Why?
| | Cysts | 2 | 1992 | 93 | 0.050 |
Why?
| | Cytoplasm | 1 | 2003 | 256 | 0.050 |
Why?
| | Immunoenzyme Techniques | 4 | 2003 | 192 | 0.050 |
Why?
| | Epithelium | 3 | 1995 | 297 | 0.050 |
Why?
| | Gene Knockdown Techniques | 2 | 2013 | 299 | 0.050 |
Why?
| | Morphogenesis | 1 | 2023 | 161 | 0.050 |
Why?
| | Prevalence | 1 | 2008 | 2257 | 0.050 |
Why?
| | Women's Health | 1 | 2004 | 271 | 0.050 |
Why?
| | Dandy-Walker Syndrome | 1 | 1981 | 7 | 0.050 |
Why?
| | Hedgehog Proteins | 1 | 2023 | 172 | 0.050 |
Why?
| | Prognosis | 2 | 2021 | 3336 | 0.050 |
Why?
| | Protein Transport | 1 | 2003 | 398 | 0.050 |
Why?
| | Milk Proteins | 2 | 1995 | 36 | 0.050 |
Why?
| | Brain | 2 | 2010 | 2378 | 0.050 |
Why?
| | Ephrin-B2 | 1 | 2021 | 35 | 0.050 |
Why?
| | Carrier Proteins | 1 | 2005 | 696 | 0.050 |
Why?
| | Phenylalanine | 2 | 1998 | 57 | 0.050 |
Why?
| | Enzyme Activation | 3 | 2013 | 791 | 0.050 |
Why?
| | Insulin | 1 | 2010 | 2083 | 0.050 |
Why?
| | Hydrocephalus | 1 | 1981 | 81 | 0.050 |
Why?
| | Precipitin Tests | 3 | 2004 | 89 | 0.050 |
Why?
| | Retroviridae Proteins, Oncogenic | 1 | 2000 | 10 | 0.040 |
Why?
| | Quinazolines | 2 | 2015 | 240 | 0.040 |
Why?
| | Shear Strength | 1 | 2020 | 65 | 0.040 |
Why?
| | Fetal Diseases | 1 | 1981 | 148 | 0.040 |
Why?
| | Neovascularization, Pathologic | 1 | 2022 | 281 | 0.040 |
Why?
| | Brain Diseases | 1 | 1981 | 127 | 0.040 |
Why?
| | Thiophenes | 2 | 1998 | 108 | 0.040 |
Why?
| | Fibroblasts | 2 | 2002 | 839 | 0.040 |
Why?
| | CD40 Antigens | 1 | 2000 | 82 | 0.040 |
Why?
| | Sodium Dodecyl Sulfate | 1 | 2019 | 21 | 0.040 |
Why?
| | Proteins | 3 | 2005 | 915 | 0.040 |
Why?
| | Leukocyte Disorders | 1 | 2019 | 11 | 0.040 |
Why?
| | Prenatal Diagnosis | 1 | 1981 | 168 | 0.040 |
Why?
| | Rheology | 1 | 2020 | 86 | 0.040 |
Why?
| | Carcinoma | 2 | 1995 | 199 | 0.040 |
Why?
| | Transendothelial and Transepithelial Migration | 1 | 2019 | 29 | 0.040 |
Why?
| | Immune System Diseases | 1 | 2019 | 34 | 0.040 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2003 | 396 | 0.040 |
Why?
| | Proto-Oncogene Proteins | 1 | 2003 | 609 | 0.040 |
Why?
| | Oxidoreductases, N-Demethylating | 1 | 1999 | 10 | 0.040 |
Why?
| | Neutrophil Activation | 1 | 2019 | 94 | 0.040 |
Why?
| | Autocrine Communication | 1 | 1999 | 42 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2013 | 401 | 0.040 |
Why?
| | Aryl Hydrocarbon Hydroxylases | 1 | 1999 | 41 | 0.040 |
Why?
| | Calcium-Binding Proteins | 1 | 2020 | 205 | 0.040 |
Why?
| | Vanadates | 1 | 1998 | 13 | 0.040 |
Why?
| | Aged, 80 and over | 3 | 2007 | 6358 | 0.040 |
Why?
| | Pain | 2 | 1993 | 709 | 0.040 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 1999 | 108 | 0.040 |
Why?
| | Genes, p53 | 1 | 1998 | 61 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2021 | 697 | 0.040 |
Why?
| | Retrospective Studies | 5 | 2007 | 12597 | 0.040 |
Why?
| | Biocompatible Materials | 1 | 2022 | 369 | 0.040 |
Why?
| | Glycosylation | 1 | 1998 | 131 | 0.040 |
Why?
| | Mucin-2 | 1 | 2017 | 3 | 0.040 |
Why?
| | Adenosine | 1 | 2019 | 204 | 0.040 |
Why?
| | Phosphoproteins | 1 | 2000 | 298 | 0.040 |
Why?
| | Oligodeoxyribonucleotides | 1 | 1998 | 138 | 0.040 |
Why?
| | Glycosaminoglycans | 1 | 1998 | 79 | 0.040 |
Why?
| | Cell Adhesion | 3 | 2014 | 430 | 0.040 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2018 | 32 | 0.040 |
Why?
| | Cross-Sectional Studies | 1 | 2008 | 4419 | 0.040 |
Why?
| | Mutagenesis | 1 | 1998 | 170 | 0.040 |
Why?
| | Ki-67 Antigen | 1 | 2018 | 104 | 0.040 |
Why?
| | Light | 1 | 2020 | 335 | 0.040 |
Why?
| | Predictive Value of Tests | 3 | 2007 | 1816 | 0.040 |
Why?
| | Receptor, Angiotensin, Type 1 | 2 | 2008 | 21 | 0.040 |
Why?
| | Graft Rejection | 1 | 2000 | 532 | 0.040 |
Why?
| | Dipeptides | 2 | 2008 | 48 | 0.040 |
Why?
| | DNA, Complementary | 2 | 2010 | 258 | 0.040 |
Why?
| | Transcription, Genetic | 4 | 2000 | 1317 | 0.040 |
Why?
| | Neuregulins | 1 | 2017 | 7 | 0.040 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2017 | 55 | 0.040 |
Why?
| | Tumor Burden | 1 | 2018 | 260 | 0.040 |
Why?
| | Extracellular Space | 1 | 1997 | 117 | 0.040 |
Why?
| | Hypertrophy | 2 | 2008 | 112 | 0.040 |
Why?
| | Prostaglandin-Endoperoxide Synthases | 1 | 1997 | 58 | 0.040 |
Why?
| | Models, Biological | 2 | 2020 | 1638 | 0.030 |
Why?
| | Prostaglandins | 1 | 1997 | 78 | 0.030 |
Why?
| | Spleen | 2 | 2010 | 486 | 0.030 |
Why?
| | Survival Rate | 1 | 2021 | 1650 | 0.030 |
Why?
| | Catheterization, Central Venous | 1 | 1997 | 81 | 0.030 |
Why?
| | Surveys and Questionnaires | 1 | 2008 | 4645 | 0.030 |
Why?
| | Neoplasm Invasiveness | 2 | 2007 | 443 | 0.030 |
Why?
| | Foreign Bodies | 1 | 1997 | 99 | 0.030 |
Why?
| | COS Cells | 2 | 2007 | 175 | 0.030 |
Why?
| | Mice, Inbred DBA | 2 | 1994 | 173 | 0.030 |
Why?
| | Adaptation, Physiological | 1 | 2019 | 481 | 0.030 |
Why?
| | CHO Cells | 2 | 2007 | 138 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2018 | 524 | 0.030 |
Why?
| | Uterus | 1 | 1977 | 192 | 0.030 |
Why?
| | Cricetinae | 2 | 2007 | 259 | 0.030 |
Why?
| | Cyclophosphamide | 2 | 2006 | 217 | 0.030 |
Why?
| | Repressor Proteins | 1 | 1998 | 368 | 0.030 |
Why?
| | Fluorouracil | 2 | 2006 | 153 | 0.030 |
Why?
| | Transforming Growth Factor beta | 2 | 1995 | 448 | 0.030 |
Why?
| | Paclitaxel | 2 | 2006 | 190 | 0.030 |
Why?
| | Immunoblotting | 2 | 2008 | 282 | 0.030 |
Why?
| | Caco-2 Cells | 3 | 1999 | 66 | 0.030 |
Why?
| | Genes, Dominant | 2 | 2006 | 94 | 0.030 |
Why?
| | Receptors, Growth Factor | 1 | 1994 | 49 | 0.030 |
Why?
| | Cerebral Angiography | 1 | 1975 | 111 | 0.030 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2000 | 965 | 0.030 |
Why?
| | Wiskott-Aldrich Syndrome Protein Family | 1 | 2014 | 3 | 0.030 |
Why?
| | 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase | 1 | 2014 | 5 | 0.030 |
Why?
| | Heart Transplantation | 1 | 2000 | 671 | 0.030 |
Why?
| | Receptors, Fibroblast Growth Factor | 1 | 1994 | 63 | 0.030 |
Why?
| | Myelin Proteins | 1 | 2014 | 45 | 0.030 |
Why?
| | Biopsy, Large-Core Needle | 1 | 2014 | 11 | 0.030 |
Why?
| | Age Factors | 3 | 2009 | 2900 | 0.030 |
Why?
| | Carcinoma in Situ | 1 | 2014 | 43 | 0.030 |
Why?
| | Proteoglycans | 1 | 2014 | 107 | 0.030 |
Why?
| | Mammary Neoplasms, Experimental | 1 | 1994 | 64 | 0.030 |
Why?
| | Demyelinating Diseases | 1 | 2014 | 75 | 0.030 |
Why?
| | Risk Factors | 4 | 2010 | 8658 | 0.030 |
Why?
| | Liver Regeneration | 1 | 1993 | 32 | 0.030 |
Why?
| | Gene Expression | 2 | 1998 | 1424 | 0.030 |
Why?
| | Lidocaine | 1 | 1993 | 41 | 0.030 |
Why?
| | Radiology, Interventional | 1 | 1993 | 28 | 0.030 |
Why?
| | Injections, Subcutaneous | 1 | 1993 | 133 | 0.030 |
Why?
| | Fibroblast Growth Factors | 1 | 1994 | 162 | 0.030 |
Why?
| | Mitogens | 1 | 1993 | 58 | 0.030 |
Why?
| | Adenoviridae | 2 | 2005 | 184 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-vav | 1 | 2013 | 1 | 0.030 |
Why?
| | Cloning, Molecular | 1 | 1994 | 524 | 0.030 |
Why?
| | Hydroxamic Acids | 2 | 2006 | 80 | 0.030 |
Why?
| | Menstrual Cycle | 1 | 1993 | 108 | 0.030 |
Why?
| | Metallothionein | 1 | 1992 | 24 | 0.030 |
Why?
| | Stomach Diseases | 1 | 1992 | 19 | 0.030 |
Why?
| | Aspartic Acid Endopeptidases | 1 | 2012 | 21 | 0.030 |
Why?
| | Recombinant Proteins | 2 | 2010 | 1237 | 0.030 |
Why?
| | Antigens | 1 | 2014 | 318 | 0.030 |
Why?
| | Keratins | 1 | 1993 | 176 | 0.030 |
Why?
| | Pregnancy Complications | 1 | 1977 | 430 | 0.030 |
Why?
| | Polymerase Chain Reaction | 2 | 2010 | 1000 | 0.030 |
Why?
| | Mammary Tumor Virus, Mouse | 1 | 1992 | 41 | 0.030 |
Why?
| | Contrast Media | 1 | 1975 | 369 | 0.030 |
Why?
| | Retroviridae | 2 | 2005 | 90 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2013 | 271 | 0.030 |
Why?
| | Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2011 | 6 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2013 | 115 | 0.020 |
Why?
| | Pregnancy | 3 | 1995 | 5525 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2015 | 724 | 0.020 |
Why?
| | Gastrointestinal Microbiome | 1 | 2018 | 502 | 0.020 |
Why?
| | Preoperative Care | 1 | 1993 | 319 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2011 | 114 | 0.020 |
Why?
| | Genes, BRCA2 | 1 | 2010 | 24 | 0.020 |
Why?
| | Genes, BRCA1 | 1 | 2010 | 31 | 0.020 |
Why?
| | Homeodomain Proteins | 2 | 2007 | 464 | 0.020 |
Why?
| | Preoperative Period | 1 | 2010 | 103 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 3 | 2003 | 2216 | 0.020 |
Why?
| | Receptors, CCR1 | 1 | 2010 | 2 | 0.020 |
Why?
| | Body Fluids | 1 | 2010 | 57 | 0.020 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2005 | 371 | 0.020 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2011 | 225 | 0.020 |
Why?
| | SEER Program | 1 | 2010 | 196 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 138 | 0.020 |
Why?
| | Gene Amplification | 1 | 2010 | 95 | 0.020 |
Why?
| | Elective Surgical Procedures | 1 | 2010 | 153 | 0.020 |
Why?
| | Cerebral Cortex | 1 | 2012 | 381 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 1987 | 317 | 0.020 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1990 | 140 | 0.020 |
Why?
| | Exons | 1 | 2010 | 301 | 0.020 |
Why?
| | Recombination, Genetic | 1 | 2010 | 176 | 0.020 |
Why?
| | bcl-2-Associated X Protein | 1 | 2009 | 45 | 0.020 |
Why?
| | Alabama | 1 | 1988 | 28 | 0.020 |
Why?
| | Helicobacter pylori | 1 | 2009 | 30 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2000 | 353 | 0.020 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2010 | 171 | 0.020 |
Why?
| | Proteomics | 1 | 2014 | 844 | 0.020 |
Why?
| | DNA | 4 | 1999 | 1353 | 0.020 |
Why?
| | Tyrphostins | 1 | 2008 | 13 | 0.020 |
Why?
| | Epitopes | 2 | 1990 | 436 | 0.020 |
Why?
| | Tissue Array Analysis | 1 | 2008 | 49 | 0.020 |
Why?
| | Intracellular Membranes | 1 | 2008 | 73 | 0.020 |
Why?
| | GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2008 | 14 | 0.020 |
Why?
| | Skin Neoplasms | 1 | 1995 | 758 | 0.020 |
Why?
| | Caspase 3 | 1 | 2009 | 237 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2009 | 213 | 0.020 |
Why?
| | Exocytosis | 1 | 2008 | 89 | 0.020 |
Why?
| | Axilla | 1 | 2007 | 39 | 0.020 |
Why?
| | Adenocarcinoma | 1 | 1994 | 795 | 0.020 |
Why?
| | Mice, Inbred BALB C | 3 | 1995 | 1155 | 0.020 |
Why?
| | Laminin | 1 | 1987 | 69 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2011 | 1133 | 0.020 |
Why?
| | Premenopause | 1 | 2007 | 107 | 0.020 |
Why?
| | src-Family Kinases | 1 | 2008 | 88 | 0.020 |
Why?
| | Fibronectins | 1 | 1987 | 108 | 0.020 |
Why?
| | Cricetulus | 1 | 2007 | 97 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2008 | 339 | 0.020 |
Why?
| | Calcimycin | 1 | 2006 | 47 | 0.020 |
Why?
| | Lymphatic Metastasis | 1 | 2007 | 275 | 0.020 |
Why?
| | Fixatives | 1 | 1986 | 16 | 0.020 |
Why?
| | Growth and Development | 1 | 2006 | 6 | 0.020 |
Why?
| | Histocytochemistry | 1 | 1986 | 78 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2006 | 119 | 0.020 |
Why?
| | Artifacts | 1 | 2006 | 123 | 0.020 |
Why?
| | Binding Sites | 2 | 2005 | 1173 | 0.020 |
Why?
| | Antigens, Surface | 1 | 1986 | 151 | 0.020 |
Why?
| | Bone Marrow Transplantation | 1 | 2007 | 241 | 0.020 |
Why?
| | Equipment Failure Analysis | 1 | 2006 | 135 | 0.020 |
Why?
| | Phantoms, Imaging | 1 | 2006 | 137 | 0.020 |
Why?
| | Liver | 1 | 1993 | 1688 | 0.020 |
Why?
| | Organ Specificity | 1 | 1986 | 270 | 0.020 |
Why?
| | Specimen Handling | 1 | 2006 | 155 | 0.020 |
Why?
| | Ionophores | 1 | 2005 | 22 | 0.020 |
Why?
| | Oligonucleotides | 1 | 2006 | 138 | 0.020 |
Why?
| | Lac Operon | 1 | 2005 | 44 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2014 | 4430 | 0.020 |
Why?
| | Guanylate Kinases | 1 | 2005 | 13 | 0.020 |
Why?
| | Rabbits | 1 | 2006 | 750 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2003 | 1860 | 0.020 |
Why?
| | Type C Phospholipases | 1 | 2005 | 66 | 0.020 |
Why?
| | Two-Hybrid System Techniques | 1 | 2005 | 52 | 0.020 |
Why?
| | Aorta | 1 | 2008 | 394 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2006 | 387 | 0.020 |
Why?
| | Guinea Pigs | 2 | 1996 | 149 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2006 | 1036 | 0.010 |
Why?
| | Alkaline Phosphatase | 1 | 2005 | 144 | 0.010 |
Why?
| | Chemokine CXCL6 | 1 | 2004 | 2 | 0.010 |
Why?
| | Chemokine CXCL16 | 1 | 2004 | 4 | 0.010 |
Why?
| | Receptors, Scavenger | 1 | 2004 | 16 | 0.010 |
Why?
| | Culture Media, Conditioned | 2 | 1995 | 105 | 0.010 |
Why?
| | RNA | 1 | 2010 | 810 | 0.010 |
Why?
| | Neoadjuvant Therapy | 1 | 2006 | 298 | 0.010 |
Why?
| | Macrophages, Peritoneal | 1 | 2004 | 91 | 0.010 |
Why?
| | Cytodiagnosis | 1 | 2003 | 29 | 0.010 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2003 | 153 | 0.010 |
Why?
| | Acetophenones | 1 | 2003 | 14 | 0.010 |
Why?
| | Hematopoietic Stem Cells | 1 | 1986 | 344 | 0.010 |
Why?
| | Benzopyrans | 1 | 2003 | 25 | 0.010 |
Why?
| | Janus Kinase 2 | 1 | 2003 | 31 | 0.010 |
Why?
| | Catalysis | 1 | 2004 | 292 | 0.010 |
Why?
| | Neutralization Tests | 2 | 1995 | 63 | 0.010 |
Why?
| | Radioimmunoassay | 2 | 1993 | 163 | 0.010 |
Why?
| | Genetic Vectors | 1 | 2004 | 291 | 0.010 |
Why?
| | Reactive Oxygen Species | 1 | 2005 | 536 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2005 | 616 | 0.010 |
Why?
| | Fetus | 1 | 1986 | 702 | 0.010 |
Why?
| | RNA, Small Interfering | 1 | 2004 | 541 | 0.010 |
Why?
| | Cranial Fossa, Posterior | 1 | 1981 | 17 | 0.010 |
Why?
| | B7-2 Antigen | 1 | 2000 | 25 | 0.010 |
Why?
| | Mice, Inbred A | 1 | 2000 | 45 | 0.010 |
Why?
| | Immune Sera | 1 | 2000 | 79 | 0.010 |
Why?
| | Antibodies, Blocking | 1 | 2000 | 32 | 0.010 |
Why?
| | CD28 Antigens | 1 | 2000 | 47 | 0.010 |
Why?
| | B7-1 Antigen | 1 | 2000 | 54 | 0.010 |
Why?
| | Injections, Intraperitoneal | 1 | 2000 | 100 | 0.010 |
Why?
| | CD40 Ligand | 1 | 2000 | 42 | 0.010 |
Why?
| | Lymphopenia | 1 | 2000 | 50 | 0.010 |
Why?
| | Histocompatibility Testing | 1 | 2000 | 116 | 0.010 |
Why?
| | Injections, Intravenous | 1 | 2000 | 202 | 0.010 |
Why?
| | Receptor Cross-Talk | 1 | 2000 | 20 | 0.010 |
Why?
| | Oncogene Protein v-crk | 1 | 2000 | 1 | 0.010 |
Why?
| | Retinoblastoma-Like Protein p130 | 1 | 2000 | 2 | 0.010 |
Why?
| | Genes, src | 1 | 2000 | 5 | 0.010 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2000 | 144 | 0.010 |
Why?
| | Crk-Associated Substrate Protein | 1 | 2000 | 5 | 0.010 |
Why?
| | Retinoblastoma Protein | 1 | 2000 | 52 | 0.010 |
Why?
| | src Homology Domains | 1 | 2000 | 33 | 0.010 |
Why?
| | Costs and Cost Analysis | 1 | 2001 | 197 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2006 | 1524 | 0.010 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2000 | 262 | 0.010 |
Why?
| | Oxidation-Reduction | 1 | 2003 | 926 | 0.010 |
Why?
| | Protein Binding | 1 | 2005 | 1898 | 0.010 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2000 | 174 | 0.010 |
Why?
| | Epidermis | 1 | 2000 | 149 | 0.010 |
Why?
| | Transplantation, Homologous | 1 | 2000 | 394 | 0.010 |
Why?
| | Cytoskeletal Proteins | 1 | 2000 | 145 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2000 | 325 | 0.010 |
Why?
| | Cytochrome P-450 Enzyme Inhibitors | 1 | 1999 | 4 | 0.010 |
Why?
| | Drug Resistance, Multiple | 1 | 1999 | 19 | 0.010 |
Why?
| | Pharmacokinetics | 1 | 1999 | 25 | 0.010 |
Why?
| | Ribonucleases | 1 | 1999 | 52 | 0.010 |
Why?
| | Carcinogenicity Tests | 1 | 1998 | 5 | 0.010 |
Why?
| | CCN Intercellular Signaling Proteins | 1 | 1998 | 5 | 0.010 |
Why?
| | Thiocarbamates | 1 | 1998 | 6 | 0.010 |
Why?
| | Subcellular Fractions | 1 | 1998 | 78 | 0.010 |
Why?
| | Genes, Viral | 1 | 1998 | 89 | 0.010 |
Why?
| | Rodentia | 1 | 1998 | 44 | 0.010 |
Why?
| | Cytochrome P-450 CYP3A | 1 | 1999 | 62 | 0.010 |
Why?
| | Membrane Glycoproteins | 1 | 2000 | 429 | 0.010 |
Why?
| | Coronary Disease | 1 | 2000 | 347 | 0.010 |
Why?
| | Arsenicals | 1 | 1998 | 24 | 0.010 |
Why?
| | Carcinoma, Ductal, Breast | 1 | 1999 | 76 | 0.010 |
Why?
| | Pyrrolidines | 1 | 1998 | 55 | 0.010 |
Why?
| | Substrate Specificity | 1 | 1999 | 355 | 0.010 |
Why?
| | DNA Replication | 1 | 1999 | 202 | 0.010 |
Why?
| | Foreign-Body Reaction | 1 | 1997 | 22 | 0.010 |
Why?
| | Polyethylene Terephthalates | 1 | 1997 | 15 | 0.010 |
Why?
| | Surface Properties | 1 | 1999 | 387 | 0.010 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 1998 | 147 | 0.010 |
Why?
| | Pregnancy, Multiple | 1 | 1977 | 14 | 0.010 |
Why?
| | Nitrobenzenes | 1 | 1997 | 13 | 0.010 |
Why?
| | Polyhydramnios | 1 | 1977 | 18 | 0.010 |
Why?
| | Catheters, Indwelling | 1 | 1997 | 79 | 0.010 |
Why?
| | Sulindac | 1 | 1997 | 17 | 0.010 |
Why?
| | Cyclooxygenase 2 Inhibitors | 1 | 1997 | 20 | 0.010 |
Why?
| | Cell Compartmentation | 1 | 1997 | 52 | 0.010 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 1997 | 72 | 0.010 |
Why?
| | Adolescent | 2 | 2010 | 17889 | 0.010 |
Why?
| | RNA, Neoplasm | 1 | 1997 | 81 | 0.010 |
Why?
| | Aging | 2 | 1998 | 1624 | 0.010 |
Why?
| | Cyclooxygenase 2 | 1 | 1997 | 164 | 0.010 |
Why?
| | Pyelonephritis | 1 | 1975 | 7 | 0.010 |
Why?
| | Binding, Competitive | 1 | 1996 | 195 | 0.010 |
Why?
| | Xanthomatosis | 1 | 1975 | 11 | 0.010 |
Why?
| | Cell Cycle | 1 | 1998 | 544 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1996 | 286 | 0.010 |
Why?
| | Diatrizoate | 1 | 1975 | 2 | 0.010 |
Why?
| | Caseins | 1 | 1995 | 21 | 0.010 |
Why?
| | Iothalamic Acid | 1 | 1975 | 5 | 0.010 |
Why?
| | Papilloma | 1 | 1995 | 43 | 0.010 |
Why?
| | Subtraction Technique | 1 | 1975 | 28 | 0.010 |
Why?
| | Fibroblast Growth Factor 1 | 1 | 1994 | 11 | 0.010 |
Why?
| | Fibroblast Growth Factor 7 | 1 | 1994 | 16 | 0.010 |
Why?
| | Fibroblast Growth Factor 10 | 1 | 1994 | 24 | 0.010 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 2 | 1 | 1994 | 21 | 0.010 |
Why?
| | Chronic Disease | 1 | 2000 | 1594 | 0.010 |
Why?
| | Drosophila | 1 | 1996 | 133 | 0.010 |
Why?
| | Blotting, Northern | 1 | 1994 | 193 | 0.010 |
Why?
| | Integrins | 1 | 1995 | 79 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1996 | 512 | 0.010 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 1994 | 83 | 0.010 |
Why?
| | 9,10-Dimethyl-1,2-benzanthracene | 1 | 1994 | 22 | 0.010 |
Why?
| | Radiography, Interventional | 1 | 1995 | 111 | 0.010 |
Why?
| | Head | 1 | 1975 | 85 | 0.010 |
Why?
| | Lactation | 1 | 1995 | 149 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2000 | 1318 | 0.010 |
Why?
| | Pyrazoles | 1 | 1997 | 361 | 0.010 |
Why?
| | Blood Physiological Phenomena | 1 | 1993 | 14 | 0.010 |
Why?
| | Culture Media, Serum-Free | 1 | 1993 | 42 | 0.010 |
Why?
| | Radioligand Assay | 1 | 1993 | 44 | 0.010 |
Why?
| | Carotid Arteries | 1 | 1975 | 183 | 0.010 |
Why?
| | Thymidine | 1 | 1993 | 58 | 0.010 |
Why?
| | Chromatography, Gel | 1 | 1993 | 125 | 0.010 |
Why?
| | Mice, Nude | 1 | 1995 | 631 | 0.010 |
Why?
| | Sulfonamides | 1 | 1997 | 445 | 0.010 |
Why?
| | Osmolar Concentration | 1 | 1993 | 174 | 0.010 |
Why?
| | Biological Factors | 1 | 1993 | 36 | 0.010 |
Why?
| | Movement | 1 | 1975 | 246 | 0.010 |
Why?
| | Hepatectomy | 1 | 1993 | 137 | 0.010 |
Why?
| | Cell Count | 1 | 1993 | 304 | 0.010 |
Why?
| | Insulin-Like Growth Factor I | 1 | 1994 | 286 | 0.010 |
Why?
| | Gastric Juice | 1 | 1992 | 5 | 0.010 |
Why?
| | Hydrochloric Acid | 1 | 1992 | 8 | 0.010 |
Why?
| | Animals, Newborn | 1 | 1994 | 779 | 0.010 |
Why?
| | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 1992 | 27 | 0.010 |
Why?
| | Isoquinolines | 1 | 1992 | 36 | 0.010 |
Why?
| | Rats, Inbred Strains | 1 | 1992 | 376 | 0.010 |
Why?
| | Nucleic Acid Hybridization | 1 | 1992 | 188 | 0.010 |
Why?
| | Child | 1 | 2010 | 18468 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 1992 | 410 | 0.010 |
Why?
| | Piperazines | 1 | 1992 | 313 | 0.010 |
Why?
| | Trypsin | 1 | 1990 | 67 | 0.010 |
Why?
| | Endopeptidases | 1 | 1990 | 72 | 0.010 |
Why?
| | Disulfides | 1 | 1990 | 90 | 0.010 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 1990 | 474 | 0.000 |
Why?
| | Renal Artery | 1 | 1975 | 26 | 0.000 |
Why?
| | Biopsy | 1 | 1975 | 1050 | 0.000 |
Why?
|
|
Dempsey's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|